Keyphrases
Percutaneous Coronary Intervention
100%
Orsiro Stent
79%
Sirolimus
79%
Clinical Outcome
77%
Stent
73%
Anti-CD34 Antibody
73%
Dual Therapy
73%
Acute Coronary Syndrome
53%
Clinical Comparison
48%
Randomized Clinical
48%
Target Lesion Failure
42%
Rate Ratio
34%
Randomized Trial
32%
Biodegradable Polymer Drug-eluting Stents
32%
Biodegradable Polymers
30%
Scandinavian
30%
Coronary Intervention
28%
Target Lesion Revascularization
27%
Confidence Interval
27%
Revascularization
26%
Registry Study
26%
Ultra-thin Strut
26%
Sirolimus-eluting Stent
24%
Biodegradable Polymer Biolimus-eluting Stents
24%
Pharmaceutical Treatment
24%
Nationwide Registry
24%
Line Assay
24%
Chronic Coronary Syndrome
24%
ST-elevation Myocardial Infarction (STEMI)
24%
Elective Patients
24%
Elastin Gene
24%
Cutis Laxa
24%
Ticagrelor
24%
Percutaneous Intervention
24%
Occlusion Therapy
24%
Complex Arrhythmias
24%
P2Y12 Inhibitors
24%
Autosomal Dominant Cutis Laxa
24%
Acute Coronary Occlusion
24%
Pericardiocentesis
24%
Coronary Perforation
24%
Stepped-wedge Trial
24%
Cardiac Death
23%
Myocardial Infarction
23%
Prasugrel
22%
Clopidogrel
19%
Chronic Total Occlusion
18%
Stent Thrombosis
16%
Elective Percutaneous Coronary Intervention
14%
Multi-slice Computed Tomography
13%
Medicine and Dentistry
Rapamycin
100%
Percutaneous Coronary Intervention
65%
Acute Coronary Syndrome
65%
Target Lesion
52%
Revascularization
52%
Target Lesion Revascularization
40%
Heart Death
38%
Stenosis
32%
Diabetes Mellitus
32%
Myocardial Infarction
30%
Heart Muscle Ischemia
29%
Umirolimus
26%
Coronary Angiography
24%
Coronary Occlusion
24%
Primary Percutaneous Coronary Intervention
24%
Coronary Computed Tomography Angiography
24%
Conditioning
24%
Left Coronary Artery
24%
Autosomal Dominant Inheritance
24%
Diabetes
24%
Randomized Controlled Trial
24%
Elastin
24%
Acute Heart Infarction
24%
Heart Muscle Revascularization
24%
Chronic Total Occlusion
24%
Cardiovascular Disease
24%
Coronary Artery Perforation
24%
Pericardiocentesis
24%
Intention-to-Treat Analysis
21%
Arm
21%
Multidetector Computed Tomography
19%
Heart Failure
15%
Drug-Eluting Stent
12%
Ischemic Heart Disease
12%
Alcohol Withdrawal Syndrome
12%
Coronary Artery Disease
11%
Attributable Risk
10%
Patient Referral
9%
Stent Thrombosis
8%
Randomized Clinical Trial
8%
Noninferiority Trial
8%
ST Segment Elevation Myocardial Infarction
8%
Bleeding
8%
Endothelial Progenitor Cell
8%
Patient Population
8%
Adverse Event
7%
Diagnostic Test
6%
Invasive Procedure
6%
Edema
6%
Clinical Finding
6%
Nursing and Health Professions
Clinical Outcome
75%
Stent
73%
Drug Eluting Coronary Stent
53%
Revascularization
52%
Rapamycin
51%
Acute Coronary Syndrome
48%
Percutaneous Coronary Intervention
26%
Heart Death
25%
Computed Tomographic Angiography
24%
Diabetes Mellitus
24%
Heart Muscle Revascularization
24%
Heart Muscle Ischemia
24%
Acute Heart Infarction
24%
Coronary Angiography
24%
Rate Ratio
19%
Confidence Interval
17%
Target Lesion Revascularization
16%
Heart Infarction
14%
Heart Failure
13%
ST Segment Elevation Myocardial Infarction
10%
Stent Thrombosis
8%
Intention to Treat Analysis
6%
Reperfusion
6%
Ischemia
6%
Diagnostic Test
6%